Molecule shown to produce cognitive improvement in rodents with early Alzheimer's disease
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
BioWorld15d
Amylyx and Gubra collaborate to develop long-acting GLP-1 receptor antagonist
Amylyx Pharmaceuticals Inc. and Gubra A/S have established a collaboration for the development of a novel long-acting GLP-1 receptor antagonist.
AlphaGalileo18h
A molecule is shown to produce cognitive improvement in rodents with early Alzheimer's disease
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...